Researchers compared 3 immunochromatographic assays (Sienna™, Wondfo®, and Prometheus™) to detect antibodies against SARS-CoV-2 in serum samples, using RT-qPCR as a reference.
Research results highlighted the need for continued supplemental NAATs for oropharyngeal samples being tested for Nisseria gonorrhoeae.
Results are provided within 15 minutes and can be read directly from the testing card.
Neutrophil-to-lymphocyte ratio may be a valuable biomarker to help clinicians recognize severe COVID-19 infection with moderate to severe ARDS.
Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections.
A novel tenofovir urine immunoassay demonstrated predictive utility and may adequately determine PrEP adherence.
By providing bundled HIV and HCV testing, substance use disorder treatment programs may create increased awareness of infection status among people with substance abuse disorders.
A team of researchers performed a systematic review to assess the methodologic quality of studies on the use of chest computed tomographic (CT) imaging in patients with COVID-19 and to determine the frequency of different chest CT findings.
Existing evidence on the diagnostic accuracy of serological tests for COVID-19 is characterized by high risks of bias and heterogeneity.
A study evaluated 5 commercially available assays that are approved for HIV seropositivity confirmation and could be readily performed in clinical laboratories.
